Biopharma

Elon Musk to step down from DOGE leadership role: Politico

In the upcoming weeks, Tesla CEO Elon Musk is expected to step down from his pos...

With biosimilar competition looming, Roche takes a hit ...

With its multiple sclerosis powerhouse Ocrevus expected to lose patent protectio...

'Patently illegal': NIH and HHS face new lawsuit over $...

The American Public Health Association and several researchers are suing the NIH...

For struggling cell and gene therapy field, Peter Marks...

To innovators in the cell and gene therapy field, Peter Marks’ exit from the FDA...

‘Patently illegal’: NIH and HHS face new lawsuit over $...

The American Public Health Association and several researchers are suing the NIH...

Cerevance fails phase 2 trial in early, untreated Parki...

Cerevance’s attempt to unlock the first-line Parkinson's disease market has hit ...

STAT+: Trump administration begins mass cuts of federal...

ASPE and AHRQ are losing key research staff as part of the HHS cuts Tuesday. Cur...

British biotech CellCentric expands to Boston with plan...

British biotech CellCentric is settling into a new office in Boston, part of the...

Functional Near-Infrared Spectroscopy Plus Virtual Real...

WEDNESDAY, April 2, 2025 -- Functional near-infrared spectroscopy (fINRS) can c...

Similar Mortality Benefit Seen for Concentrated, Evenly...

WEDNESDAY, April 2, 2025 -- Engaging in physical activity concentrated within o...

At-Home Smell Test Can Help ID Risk for Cognitive Impai...

WEDNESDAY, April 2, 2025 -- The digital remote AROMHA Brain Health Test (ABHT) ...

AGA Finds No Clear Evidence for or Against AI-Assisted ...

WEDNESDAY, April 2, 2025 -- In a living clinical practice guideline issued by t...

ACC: Semaglutide Beneficial in Patients With T2DM and P...

WEDNESDAY, April 2, 2025 -- For patients with symptomatic peripheral artery dis...

ACC: 1999 to 2022 Saw Increase in Maternal Mortality Du...

WEDNESDAY, April 2, 2025 -- From 1999 to 2022, there was a considerable increas...

ACC: Cardiac Arrest Incidence at Long-Distance Races Re...

WEDNESDAY, April 2, 2025 -- Despite increased participation in U.S. long-distanc...

ACC: Microplastic Exposure Tied to Chronic Disease Prev...

WEDNESDAY, April 2, 2025 -- Microplastic exposure may increase the risk for chr...

Princeton and Harvard join other Ivy League schools fac...

The Trump administration is halting research funding to Princeton University and...

Medtronic inks stroke AI partnership with European deve...

The medtech giant plans to integrate Methinks AI’s apps with its portfolio of is...

Japan's Marubeni takes on Sumitomo's Asia pharma busine...

Japanese conglomerate Marubeni is getting a 60% stake in the new company for 45 ...

STAT+: FTC suit over PBMs’ insulin pricing is delayed i...

A controversial lawsuit brought by the FTC against the largest PBMs over insulin...

Supreme Court sides with the FDA in its dispute over sw...

The Supreme Court on Wednesday ruled for the FDA in its crackdown on sweet-flavo...

Leqembi’s EU review drags on; Sanofi gets a new develop...

The European Commission has referred Eisai and Biogen’s application to an appeal...

New genetic medicine CDMO acquires Landmark Bio

Artis BioSolutions joins a host of startups trying to improve development and ma...

FDA device office hit in HHS layoffs

Teams working on device communications and policy were cut from the agency on Tu...

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.